The synthetic version of exendin-4, exenatide, shares a 53% amino acid sequence homology with human GLP-1 [18] and has been investigated in treating PD
These data suggest inhibition of prolonged AMPK activation may improve the survival of beta cells under the condition of glucotoxicity
Are their products tested for quality
Current research presents a complex picture that requires careful interpretation, as studies have yielded mixed results depending on the specific agent studied, patient population, duration of treatment, and methodology employed
A responsible medical discussion should include possible benefits, limitations, risks, alternatives, red flags, and a plan for monitoring progress